Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 811.26 billion as of April 29, 2026. Its market cap has increased by 27.67% in one year.

Market Cap

811.26B

Enterprise Value

800.21B

Revenue

331.82B

Ranking

n/a

PE Ratio

23.27

Stock Price

1,396.80

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 811.26B, an increase of 8,347.78%. That is a compound annual growth rate of 20.45%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	811.26B	18.07%
Dec 31, 2025	687.09B	-11.35%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Mankind Pharma	936.58B
Zydus Lifesciences	945.51B
Glenmark Pharmaceuticals	656.15B
Alkem Laboratories	638.96B
Cipla	1,064.01B
Laurus Labs	606.56B
Divi's Laboratories	1,719.44B
Ipca Laboratories	391.03B

Market Cap Rankings